Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:budesonide
go back to main search page
Accession:CHEBI:3207 term browser browse the term
Definition:A glucocorticoid steroid having a highly oxygenated pregna-1,4-diene structure. It is used mainly in the treatment of asthma and non-infectious rhinitis and for treatment and prevention of nasal polyposis.
Synonyms:exact_synonym: 11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
 related_synonym: (11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione;   Formula=C25H34O6;   InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1;   InChIKey=VOVIALXJUBGFJZ-KWVAZRHASA-N;   SMILES=[H][C@@]12CCC3=CC(=O)C=C[C@]3(C)[C@@]1([H])[C@@H](O)C[C@@]1(C)[C@@]2([H])C[C@H]2OC(CCC)O[C@@]12C(=O)CO
 xref: CAS:51333-22-3;   DrugBank:DB01222;   Drug_Central:419;   KEGG:D00246
 xref_mesh: MESH:D019819
 xref: PMID:21616561;   Patent:DE2323215;   Patent:US3929768;   Wikipedia:Budesonide



show annotations for term's descendants           Sort by:
budesonide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb11 ATP binding cassette subfamily B member 11 multiple interactions
decreases activity
ISO Budesonide inhibits the reaction [ABCB11 protein results in increased transport of Taurocholic Acid]
Budesonide results in decreased activity of ABCB11 protein
CTD PMID:24014644 NCBI chr 3:54,016,854...54,112,797
Ensembl chr 3:54,017,127...54,112,730
JBrowse link
G Abcb1a ATP binding cassette subfamily B member 1A increases expression ISO Budesonide results in increased expression of ABCB1 protein CTD PMID:22464980 NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
JBrowse link
G Adrb2 adrenoceptor beta 2 increases expression ISO Budesonide results in increased expression of ADRB2 protein CTD PMID:20061444 NCBI chr18:55,642,459...55,644,501
Ensembl chr18:55,502,903...55,644,512
JBrowse link
G Ar androgen receptor multiple interactions ISO Budesonide binds to and results in decreased activity of AR protein; Budesonide inhibits the reaction [Metribolone results in increased activity of AR protein] CTD PMID:18324785 PMID:25752796 NCBI chr  X:63,104,771...63,273,934
Ensembl chr  X:63,104,771...63,273,925
JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression ISO Budesonide results in decreased expression of BCL2 protein CTD PMID:15475437 NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743
Ensembl chr13:22,684,989...22,853,743
JBrowse link
G Bglap bone gamma-carboxyglutamate protein decreases expression ISO Budesonide results in decreased expression of BGLAP protein CTD PMID:9232087 NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 decreases expression ISO Budesonide results in decreased expression of BIRC5 mRNA CTD PMID:17163412 NCBI chr10:103,072,530...103,081,382
Ensembl chr10:103,073,408...103,081,380
JBrowse link
G Casp3 caspase 3 decreases expression ISO Budesonide results in decreased expression of CASP3 mRNA CTD PMID:17163412 NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
JBrowse link
G Casp9 caspase 9 increases activity ISO Budesonide results in increased activity of CASP9 protein CTD PMID:11734450 NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
JBrowse link
G Ccl11 C-C motif chemokine ligand 11 multiple interactions ISO Budesonide inhibits the reaction [IL13 protein results in increased expression of CCL11 protein] CTD PMID:17988555 NCBI chr10:67,028,328...67,032,929
Ensembl chr10:67,028,328...67,032,926
JBrowse link
G Ccl17 C-C motif chemokine ligand 17 decreases expression ISO Budesonide results in decreased expression of CCL17 protein CTD PMID:15679716 NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819
JBrowse link
G Ccl2 C-C motif chemokine ligand 2 decreases expression
multiple interactions
ISO
EXP
Budesonide results in decreased expression of CCL2 protein
Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 mRNA]; Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CCL2 protein]
CTD PMID:15734790 PMID:20116850 NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
JBrowse link
G Ccl3 C-C motif chemokine ligand 3 increases expression ISO Budesonide results in increased expression of CCL3 protein CTD PMID:20116850 NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
JBrowse link
G Ccl4 C-C motif chemokine ligand 4 increases expression ISO Budesonide results in increased expression of CCL4 protein CTD PMID:20116850 NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
JBrowse link
G Ccl5 C-C motif chemokine ligand 5 multiple interactions ISO Budesonide inhibits the reaction [TNF protein results in increased secretion of CCL5 mRNA]; Budesonide inhibits the reaction [TNF protein results in increased secretion of CCL5 protein] CTD PMID:10903220 PMID:14643170 NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
JBrowse link
G Ccnb2 cyclin B2 decreases expression ISO Budesonide results in decreased expression of CCNB2 mRNA CTD PMID:17163412 NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
JBrowse link
G Ccne1 cyclin E1 decreases expression ISO Budesonide results in decreased expression of CCNE1 mRNA CTD PMID:17163412 NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
JBrowse link
G Cdkn1a cyclin-dependent kinase inhibitor 1A multiple interactions
increases expression
ISO Budesonide inhibits the reaction [vinyl carbamate results in decreased expression of CDKN1A protein]
Budesonide results in increased expression of CDKN1A mRNA
CTD PMID:12117777 NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
JBrowse link
G Cdkn1b cyclin-dependent kinase inhibitor 1B multiple interactions ISO Budesonide inhibits the reaction [vinyl carbamate results in decreased expression of CDKN1B protein] CTD PMID:12117777 NCBI chr 4:167,760,067...167,765,177
Ensembl chr 4:167,760,181...167,764,982
JBrowse link
G Csf2 colony stimulating factor 2 multiple interactions
decreases secretion
increases activity
ISO Budesonide inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]
Budesonide results in decreased secretion of CSF2 protein
Budesonide results in increased activity of CSF2 protein
CTD PMID:7621058 PMID:10460758 PMID:10868704 PMID:11730731 NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
JBrowse link
G Cxcl1 C-X-C motif chemokine ligand 1 multiple interactions EXP Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CXCL1 mRNA]; Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CXCL1 protein] CTD PMID:15734790 NCBI chr14:17,193,364...17,195,143
Ensembl chr14:17,193,365...17,195,215
JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 multiple interactions EXP Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CXCL2 mRNA]; Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CXCL2 protein] CTD PMID:15734790 NCBI chr14:17,181,030...17,183,075
Ensembl chr14:17,181,062...17,183,075
JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 multiple interactions EXP Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CXCL3 mRNA]; Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of CXCL3 protein] CTD PMID:15734790 NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
JBrowse link
G Cyp3a2 cytochrome P450, family 3, subfamily a, polypeptide 2 decreases expression
multiple interactions
increases expression
EXP
ISO
Budesonide results in decreased expression of CYP3A2 mRNA
[Budesonide results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA
Budesonide results in increased expression of CYP3A4 mRNA
CTD PMID:19562681 PMID:20888898 PMID:25455453 NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
JBrowse link
G Cyp3a9 cytochrome P450, family 3, subfamily a, polypeptide 9 increases expression
multiple interactions
EXP
ISO
Budesonide results in increased expression of CYP3A9 mRNA
Budesonide results in increased expression of CYP3A5 mRNA
Ketoconazole inhibits the reaction [Budesonide results in increased expression of CYP3A5 mRNA]; Mifepristone inhibits the reaction [Budesonide results in increased expression of CYP3A5 mRNA]
CTD PMID:12538830 PMID:19562681 PMID:20888898 PMID:24555085 NCBI chr12:16,806,222...16,846,428
Ensembl chr12:16,806,207...16,846,422
JBrowse link
G Epx eosinophil peroxidase multiple interactions EXP Budesonide inhibits the reaction [sephadex results in increased expression of EPX protein] CTD PMID:10850854 NCBI chr10:72,666,865...72,677,952
Ensembl chr10:72,666,865...72,677,952
JBrowse link
G Gcg glucagon decreases expression
multiple interactions
EXP Budesonide results in decreased expression of GCG mRNA
[Fatty Acids co-treated with Budesonide] results in increased expression of GCG mRNA
CTD PMID:12524409 PMID:14705828 NCBI chr 3:47,113,914...47,122,958
Ensembl chr 3:47,113,914...47,122,929
JBrowse link
G Ifng interferon gamma decreases secretion
multiple interactions
ISO Budesonide results in decreased secretion of IFNG protein
[zafirlukast co-treated with Prednisone co-treated with Budesonide] inhibits the reaction [Antigens results in increased secretion of IFNG protein]
CTD PMID:7621058 PMID:16160912 NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
JBrowse link
G Igf2 insulin-like growth factor 2 multiple interactions ISO Budesonide inhibits the reaction [vinyl carbamate results in decreased methylation of IGF2 protein] CTD PMID:15824018 NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
JBrowse link
G Il13 interleukin 13 multiple interactions
increases activity
ISO Budesonide inhibits the reaction [IL13 protein results in increased expression of CCL11 protein]; Budesonide inhibits the reaction [IL13 protein results in increased expression of IL6 mRNA]; Budesonide inhibits the reaction [IL13 protein results in increased expression of IL6 protein]
Budesonide results in increased activity of IL13 protein
CTD PMID:17988555 NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
JBrowse link
G Il17a interleukin 17A multiple interactions ISO Budesonide inhibits the reaction [Ozone results in increased expression of IL17A protein]; Progesterone promotes the reaction [Budesonide inhibits the reaction [Ozone results in increased expression of IL17A protein]] CTD PMID:28279894 NCBI chr 9:23,144,402...23,147,889
Ensembl chr 9:23,144,402...23,147,889
JBrowse link
G Il1b interleukin 1 beta decreases secretion
multiple interactions
ISO
EXP
Budesonide results in decreased secretion of IL1B protein
Budesonide inhibits the reaction [[TNF protein co-treated with IL1B protein] results in decreased susceptibility to Formoterol Fumarate]; Budesonide inhibits the reaction [[TNF protein co-treated with IL1B protein] results in decreased susceptibility to Salmeterol Xinafoate]; Budesonide inhibits the reaction [[TNF protein co-treated with IL1B protein] results in decreased susceptibility to Terbutaline]; Budesonide inhibits the reaction [[TNF protein co-treated with IL1B protein] results in increased expression of PTGS2 mRNA]; Budesonide inhibits the reaction [Ozone results in increased expression of IL1B protein]
Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL1B mRNA]; Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL1B protein]
Budesonide inhibits the reaction [IL1B protein results in increased acetylation of H4C16 protein]; Budesonide inhibits the reaction [IL1B protein results in increased expression of SELE mRNA]; Budesonide inhibits the reaction [IL1B protein results in increased secretion of CSF2 protein]; Budesonide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B protein]; Hydrogen Peroxide inhibits the reaction [Budesonide inhibits the reaction [IL1B protein results in increased acetylation of H4C16 protein]]; Theophylline inhibits the reaction [Hydrogen Peroxide inhibits the reaction [Budesonide inhibits the reaction [IL1B protein results in increased acetylation of H4C16 protein]]]
CTD PMID:7621058 PMID:9371735 PMID:10460758 PMID:15337628 PMID:15734790 More... NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
JBrowse link
G Il4 interleukin 4 decreases expression ISO Budesonide results in decreased expression of IL4 protein CTD PMID:7988651 PMID:12406821 PMID:15086961 NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
JBrowse link
G Il4r interleukin 4 receptor decreases expression ISO Budesonide results in decreased expression of IL4R protein CTD PMID:15679716 NCBI chr 1:180,115,061...180,139,981
Ensembl chr 1:180,115,120...180,139,980
JBrowse link
G Il5 interleukin 5 decreases expression ISO Budesonide results in decreased expression of IL5 protein CTD PMID:7988651 PMID:12406821 PMID:15086961 NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
JBrowse link
G Il6 interleukin 6 multiple interactions EXP
ISO
Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 mRNA]; Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of IL6 protein]
Budesonide inhibits the reaction [IL13 protein results in increased expression of IL6 mRNA]; Budesonide inhibits the reaction [IL13 protein results in increased expression of IL6 protein]
Budesonide inhibits the reaction [Ozone results in increased expression of IL6 protein]; Progesterone promotes the reaction [Budesonide inhibits the reaction [Ozone results in increased expression of IL6 protein]]
CTD PMID:15734790 PMID:17988555 PMID:28279894 NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
JBrowse link
G Ins1 insulin 1 multiple interactions EXP Budesonide inhibits the reaction [Colforsin promotes the reaction [Glucose results in increased secretion of INS1 protein]]; Budesonide inhibits the reaction [Glucose results in increased secretion of INS1 protein] CTD PMID:25851902 NCBI chr 1:251,244,973...251,245,540
Ensembl chr 1:251,244,973...251,245,536
JBrowse link
G Jun Jun proto-oncogene, AP-1 transcription factor subunit decreases expression EXP Budesonide results in decreased expression of JUN mRNA CTD PMID:12524409 NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
JBrowse link
G Ltf lactotransferrin multiple interactions
decreases secretion
ISO Budesonide inhibits the reaction [methylcholine results in increased secretion of LTF protein]
Budesonide results in decreased secretion of LTF protein
CTD PMID:11112886 NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:110,999,948...111,022,795
JBrowse link
G Mapk14 mitogen activated protein kinase 14 multiple interactions ISO Budesonide inhibits the reaction [Ozone results in increased phosphorylation of MAPK14 protein] CTD PMID:28279894 NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions EXP Budesonide inhibits the reaction [Cadmium Chloride results in increased activity of MMP9 protein]; Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of MMP9 mRNA]; Budesonide promotes the reaction [Formoterol Fumarate inhibits the reaction [Cadmium Chloride results in increased activity of MMP9 protein]]; Formoterol Fumarate promotes the reaction [Budesonide inhibits the reaction [Cadmium Chloride results in increased activity of MMP9 protein]] CTD PMID:15734790 PMID:25313925 NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
JBrowse link
G Mpo myeloperoxidase multiple interactions EXP Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of MPO protein] CTD PMID:15734790 NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
JBrowse link
G Mt2A metallothionein 2A increases expression
multiple interactions
ISO Budesonide results in increased expression of MT2A mRNA
Terbutaline affects the reaction [Budesonide results in increased expression of MT2A mRNA]
CTD PMID:9973176 NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
JBrowse link
G Myc MYC proto-oncogene, bHLH transcription factor multiple interactions ISO Budesonide inhibits the reaction [Benzo(a)pyrene results in increased expression of MYC mRNA] CTD PMID:15969944 NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
JBrowse link
G Nos2 nitric oxide synthase 2 decreases expression
multiple interactions
ISO
EXP
Budesonide results in decreased expression of NOS2 mRNA
Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of NOS2 mRNA]
CTD PMID:15734790 PMID:17163412 NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 increases expression
increases activity
multiple interactions
EXP
ISO
Budesonide results in increased expression of NR1I2 mRNA
Budesonide results in increased activity of NR1I2 protein
[Budesonide results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA
CTD PMID:19562681 PMID:25455453 NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions
decreases expression
increases activity
affects binding
ISO
EXP
2,2',3,5',6-pentachlorobiphenyl inhibits the reaction [Budesonide results in increased activity of NR3C1 protein]; 2,3',4,4',5-pentachlorobiphenyl inhibits the reaction [Budesonide results in increased activity of NR3C1 protein]; 2,4,2',4'-tetrachlorobiphenyl inhibits the reaction [Budesonide results in increased activity of NR3C1 protein]; 2,4,4'-trichlorobiphenyl inhibits the reaction [Budesonide results in increased activity of NR3C1 protein]; 2,4,5,2',4',5'-hexachlorobiphenyl inhibits the reaction [Budesonide results in increased activity of NR3C1 protein]; 2,4,5,2',5'-pentachlorobiphenyl inhibits the reaction [Budesonide results in increased activity of NR3C1 protein]; 2,5,2',5'-tetrachlorobiphenyl inhibits the reaction [Budesonide results in increased activity of NR3C1 protein]; Budesonide affects the reaction [Terbutaline results in increased expression of NR3C1 mRNA]
Budesonide results in decreased expression of NR3C1 mRNA
Budesonide binds to NR3C1 protein
[Budesonide binds to NR3C1 protein] which results in increased expression of SLC51A mRNA; [Budesonide binds to NR3C1 protein] which results in increased expression of SLC51B mRNA
CTD PMID:8977508 PMID:9973176 PMID:10335001 PMID:15362971 PMID:16507850 More... NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
JBrowse link
G Nr3c2 nuclear receptor subfamily 3, group C, member 2 increases activity ISO Budesonide results in increased activity of NR3C2 protein CTD PMID:15362971 NCBI chr19:30,715,634...31,059,885
Ensembl chr19:30,715,648...31,059,885
JBrowse link
G Pcna proliferating cell nuclear antigen decreases expression ISO Budesonide results in decreased expression of PCNA protein CTD PMID:12117777 NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
JBrowse link
G Pgr progesterone receptor multiple interactions ISO Budesonide binds to and results in increased activity of PGR protein CTD PMID:25752796 NCBI chr 8:6,072,673...6,131,552
Ensembl chr 8:6,072,673...6,131,344
JBrowse link
G Pla2g4a phospholipase A2 group 4A decreases activity ISO Budesonide results in decreased activity of PLA2G4A protein CTD PMID:15337628 NCBI chr13:61,877,818...62,022,261
Ensembl chr13:61,877,813...62,022,266
JBrowse link
G Ppara peroxisome proliferator activated receptor alpha multiple interactions ISO [Budesonide co-treated with Glucose] binds to PPARA protein; Budesonide inhibits the reaction [Glucose inhibits the reaction [Palmitoyl Coenzyme A analog binds to PPARA protein]] CTD PMID:18812576 NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
JBrowse link
G Ptges2 prostaglandin E synthase 2 multiple interactions EXP Budesonide promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGES2 protein] CTD PMID:15734790 NCBI chr 3:15,690,501...15,697,688
Ensembl chr 3:15,690,501...15,697,688
JBrowse link
G Ptgs1 prostaglandin-endoperoxide synthase 1 multiple interactions EXP Budesonide promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS1 mRNA] CTD PMID:15734790 NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO
EXP
Budesonide inhibits the reaction [[TNF protein co-treated with IL1B protein] results in increased expression of PTGS2 mRNA]
Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 mRNA]
CTD PMID:15734790 PMID:20061444 NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
JBrowse link
G Rela RELA proto-oncogene, NF-kB subunit multiple interactions EXP Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased activity of RELA protein] CTD PMID:15734790 NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
JBrowse link
G Rnase3 ribonuclease A family member 3 decreases expression ISO Budesonide results in decreased expression of RNASE3 protein CTD PMID:15612964 NCBI chr15:24,511,894...24,512,764
Ensembl chr15:24,511,891...24,512,790
JBrowse link
G Sele selectin E multiple interactions EXP
ISO
Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of SELE mRNA]
Budesonide inhibits the reaction [IL1B protein results in increased expression of SELE mRNA]
CTD PMID:9371735 PMID:15734790 NCBI chr13:76,402,841...76,412,741
Ensembl chr13:76,403,304...76,412,741
JBrowse link
G Sell selectin L multiple interactions EXP Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of SELL mRNA] CTD PMID:15734790 NCBI chr13:76,416,969...76,436,444
Ensembl chr13:76,416,915...76,436,456
JBrowse link
G Selp selectin P multiple interactions EXP Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of SELP mRNA] CTD PMID:15734790 NCBI chr13:76,476,229...76,511,846
Ensembl chr13:76,476,295...76,511,845
JBrowse link
G Slc22a2 solute carrier family 22 member 2 multiple interactions ISO Budesonide inhibits the reaction [SLC22A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003 NCBI chr 1:48,121,061...48,163,268
Ensembl chr 1:48,121,061...48,163,268
JBrowse link
G Slc22a3 solute carrier family 22 member 3 multiple interactions ISO Budesonide inhibits the reaction [SLC22A3 protein results in increased uptake of Formoterol Fumarate]; SLC22A3 protein results in increased susceptibility to [Budesonide results in decreased transport of Formoterol Fumarate] CTD PMID:17920670 PMID:21914487 NCBI chr 1:48,235,476...48,324,617
Ensembl chr 1:48,235,476...48,324,612
JBrowse link
G Slc51a solute carrier family 51 member A increases expression
multiple interactions
ISO
EXP
Budesonide results in increased expression of SLC51A mRNA
[Budesonide binds to NR3C1 protein] which results in increased expression of SLC51A mRNA
CTD PMID:19562681 NCBI chr11:68,299,086...68,313,485
Ensembl chr11:68,299,086...68,313,485
JBrowse link
G Slc51b SLC51 subunit beta increases expression
multiple interactions
ISO
EXP
Budesonide results in increased expression of SLC51B mRNA
[Budesonide binds to NR3C1 protein] which results in increased expression of SLC51B mRNA
CTD PMID:19562681 NCBI chr 8:65,931,891...65,939,953
Ensembl chr 8:65,931,890...65,940,145
JBrowse link
G Slco1b2 solute carrier organic anion transporter family member 1B2 multiple interactions ISO Budesonide inhibits the reaction [SLCO1B3 protein results in increased uptake of Mesalamine]; Budesonide inhibits the reaction [SLCO1B3 protein results in increased uptake of Sulfobromophthalein] CTD PMID:21430235 NCBI chr 4:174,551,463...174,619,988
Ensembl chr 4:174,551,480...174,619,981
JBrowse link
G Slco2b1 solute carrier organic anion transporter family, member 2b1 multiple interactions ISO Budesonide inhibits the reaction [SLCO2B1 protein results in increased uptake of Mesalamine]; Budesonide inhibits the reaction [SLCO2B1 protein results in increased uptake of Sulfobromophthalein] CTD PMID:21430235 NCBI chr 1:153,959,288...154,007,294
Ensembl chr 1:153,959,293...154,007,353
JBrowse link
G Spp1 secreted phosphoprotein 1 increases expression ISO Budesonide results in increased expression of SPP1 protein CTD PMID:21885873 NCBI chr14:5,308,885...5,315,120
Ensembl chr14:5,308,885...5,315,162
JBrowse link
G Star steroidogenic acute regulatory protein multiple interactions ISO Budesonide promotes the reaction [LG 100268 promotes the reaction [T0901317 results in increased expression of STAR mRNA]]; Budesonide promotes the reaction [LG 100268 promotes the reaction [T0901317 results in increased expression of STAR protein]]; Budesonide promotes the reaction [T0901317 promotes the reaction [LG 100268 results in increased expression of STAR protein]] CTD PMID:23362264 NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions ISO Budesonide inhibits the reaction [Ozone results in increased expression of TGFB1 protein] CTD PMID:28279894 NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
JBrowse link
G Tgm2 transglutaminase 2 increases expression ISO Budesonide results in increased expression of TGM2 protein CTD PMID:21885873 NCBI chr 3:146,772,684...146,801,924
Ensembl chr 3:146,772,687...146,801,981
JBrowse link
G Timp1 TIMP metallopeptidase inhibitor 1 multiple interactions EXP Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TIMP1 mRNA] CTD PMID:15734790 NCBI chr  X:1,212,969...1,217,714
Ensembl chr  X:1,212,972...1,217,664
JBrowse link
G Tnf tumor necrosis factor decreases expression
decreases secretion
multiple interactions
ISO
EXP
Budesonide results in decreased expression of TNF protein
Budesonide results in decreased secretion of TNF protein
Budesonide inhibits the reaction [[TNF protein co-treated with IL1B protein] results in decreased susceptibility to Formoterol Fumarate]; Budesonide inhibits the reaction [[TNF protein co-treated with IL1B protein] results in decreased susceptibility to Salmeterol Xinafoate]; Budesonide inhibits the reaction [[TNF protein co-treated with IL1B protein] results in decreased susceptibility to Terbutaline]; Budesonide inhibits the reaction [[TNF protein co-treated with IL1B protein] results in increased expression of PTGS2 mRNA]; Budesonide inhibits the reaction [Ozone results in increased expression of TNF protein]
Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF mRNA]; Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of TNF protein]
Budesonide inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]; Budesonide inhibits the reaction [TNF protein results in increased secretion of CCL5 mRNA]; Budesonide inhibits the reaction [TNF protein results in increased secretion of CCL5 protein]; Budesonide inhibits the reaction [TNF protein results in increased secretion of CXCL8 mRNA]; Budesonide inhibits the reaction [TNF protein results in increased secretion of CXCL8 protein]
CTD PMID:7621058 PMID:10100995 PMID:10903220 PMID:14643170 PMID:15589479 More... NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
JBrowse link
G Tp53 tumor protein p53 decreases expression ISO Budesonide results in decreased expression of TP53 protein CTD PMID:15475437 NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions EXP
ISO
Budesonide inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of VCAM1 mRNA]
Budesonide inhibits the reaction [TNF protein results in increased expression of VCAM1 protein]
CTD PMID:10100995 PMID:15734790 NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
JBrowse link
G Vegfa vascular endothelial growth factor A decreases expression
multiple interactions
ISO Budesonide results in decreased expression of VEGFA protein
Budesonide inhibits the reaction [Benzo(a)pyrene results in increased expression of VEGFA mRNA]; Budesonide inhibits the reaction [Benzo(a)pyrene results in increased expression of VEGFA protein]
CTD PMID:15969944 PMID:20116850 NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19808
    role 19784
      application 19627
        anti-inflammatory agent 16580
          anti-inflammatory drug 14922
            budesonide 75
Path 2
Term Annotations click to browse term
  CHEBI ontology 19808
    subatomic particle 19806
      composite particle 19806
        hadron 19806
          baryon 19806
            nucleon 19806
              atomic nucleus 19806
                atom 19806
                  main group element atom 19756
                    p-block element atom 19756
                      carbon group element atom 19705
                        carbon atom 19702
                          organic molecular entity 19702
                            heteroorganic entity 19460
                              organochalcogen compound 19224
                                organooxygen compound 19141
                                  carbonyl compound 18869
                                    ketone 17165
                                      oxyketone 8901
                                        alpha-oxyketone 8901
                                          alpha-hydroxy ketone 8901
                                            primary alpha-hydroxy ketone 7785
                                              budesonide 75
paths to the root